AskAt Inc. announced today that AskAt received a notice of allowance dated June 30, 2017 from Office of the Controller General of Patent, Designs & Trade Marks in connection with the Application No. 817/DELNP/2006, a substance patent for its EP4 antagonist(AAT-007)